Monday, 19 December 2016

FDA grants accelerated approval to Clovis's ovarian cancer drug

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Clovis Oncology Inc's ovarian cancer drug.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)